|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
AdvanDx, Inc.
| | | Phone: | (781) 376 0009 | Fax: | (781) 376 0111 | Year Established: | 2002 | Ticker: | OPGN | Exchange: | NASDAQ | Main Contact: | Evan Jones, Chairman & CEO, Opgen | | Other Contacts: | Terry Walker, Ph.D., Senior VP, R&D Charles Thornton, M.B.A., Ph.D., RAC, VP, QA & RA Geoffrey A. McKinley, Ph.D., Senior VP, R&D, Business Development Vadim Sapiro, CIO Robert McG. Lilley, CCO Timothy Dec, CFO
| | Company Description | AdvanDx is developing and marketing in vitro diagnostic kits for the diagnosis of infectious diseases based on its proprietary PNA FISH technology. These kits will provide rapid and accurate identification of microorganisms potentially leading to better patient treatment, infection control, and healthcare management. The current product line is intended for rapid and accurate identification of microorganisms in cultures.
On July 14, 2015, OpGen has agreed to acquire AdvanDx, a Woburn, Mass. developer of advanced molecular diagnostic products. The acquisition will be accounted for as a merger combination. | |
|
|
|
|
|